Laser Therapy for Metachromatic Leukodystrophy

Metachromatic leukodystrophy is a rare hereditary (genetic) disorder that causes fatty substances (lipids) to build up in cells, particularly in the brain, spinal cord and peripheral nerves.

This buildup is caused by a deficiency of an enzyme that helps break down lipids called sulfatides. Followingly, the brain and nervous system progressively lose function because the substance that covers and protects the nerve cells (myelin) is damaged.

Damage to That protective myelin covering the nerves results in progressive worsening of brain and nervous system functions, including:

·         Loss of the ability to detect sensations, such as touch, pain, heat and sound

·         Loss of intellectual, thinking and memory skills

·         Loss of motor skills, such as walking, moving, speaking and swallowing

·         Stiff, rigid muscles, poor muscle function and paralysis

·         Loss of bladder and bowel function

·         Gallbladder problems

·         Blindness

·         Hearing loss

·         Seizures

·         Emotional and behavioral problems, including unstable emotions and substance misuse.

Viewing the fact that cell damage is the main issue resulting from this disease, several treatments and medical devices have been developed to diagnose and treat that issue.

Laser therapy with the help of advanced laser machines has earned the approval of the Food and Drug Administration (FDA), especially that Over 4,000 studies have demonstrated the positive effects of this specific type of therapy.

Undoubtedly, not all laser machines are suitable and effective enough to meet these sensitive treatment requirements. Yet, the Smart Medical 26.2Watt Diode Laser SIFLASER-3.2 from SIFSOF appears to perfectly meet these medical needs.

This device has 4 wavelengths: 635nm, 810nm, 980nm and 1064nm with Maximum power of up to 26.2Watt.

Most importantly, its pulse duration is 10μs-3s. This should perfectly meet neurologists’ requirements, especially since the pulse duration is adjustable enough to suit every individual case’s needs.

Another thing is that doctors could easily track treatment times, save protocols and view patient profiles in the laser, and even update laser software through the internet.

This should render the laser treatment much easier and more transparent for both doctors and patients.

What is of most importance, though, is that Metachromatic leukodystrophy disease is basically a cell damage issue. Accordingly, one of the primary functions of SIFLASER-3.2 has been to accelerate tissue repair and cell growth among patients. But how?

Photons of light from lasers penetrate deeply into tissue and accelerate cellular reproduction and growth. The laser light increases the energy available to the cell so that the cell can take on nutrients faster and get rid of waste products.

 In this way, this Laser light gradually works on treating the damaged cells.

Leukodystrophies are progressive, so the neurological problems get worse over time which makes them usually fatal.

However, this should never eliminate any chance of recovery. With the help of the diode Laser system SIFLASER-3.2, recovery hope from Metachromatic leukodystrophy may turn into a reality.

reference: Metachromatic leukodystrophy

Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFSOF is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.

The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.